The board of directors (the "Board") of the Company wishes to...

​

The board of directors (the "Board") of the Company wishes to announce that the Company, together with CDH Genetech Limited ("CDH Genetech"), proposes to participate in the offer to acquire 100% of the shares of Sirtex Medical Limited ("Sirtex") by way of a scheme of arrangement, pursuant to which the Company will provide 49% of the equity funding for the acquisition (the "Transaction"), representing approximately AUD$473,857,072 (approximately HK$2,795,756,725). The participation of the Company is subject to reaching agreement of final documentation with CDH Genetech.